SolveBio joins Google in global alliance; Pfizer warns Facebook posts unblinding trials;

> Startup SolveBio joined the likes of Google in the Global Alliance for Genomics and Health. Piece

> Pfizer's ($PFE) Craig Lipset warned of the risks of patients unblinding trials through Facebook posts. Feature

> Wiley bought SimBioSys for its drug discovery software. Item

> Treato introduced the third generation of its social media monitoring technology. Release

> Russian CRO Synergy Research tapped Projecis for its clinical trial technology. Item

> BioClinica expanded its clinical supply chain planning and optimization technology offering. News

> Premier Biosoft rolled out version 5.0 of its glycan quantitation tool, SimGlycan. Post

> CNBC looked at how the scale of China's genome sequencing operations is straining data handling capabilities. Feature

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.